
Gustavo A. Rosario Benitez
Examiner (ID: 599, Phone: (571)270-7888 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2838 |
| Total Applications | 811 |
| Issued Applications | 625 |
| Pending Applications | 91 |
| Abandoned Applications | 129 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5666593
[patent_doc_number] => 20060171943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Compositions and methods of treating fibrotic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/344379
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15118
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20060171943.pdf
[firstpage_image] =>[orig_patent_app_number] => 11344379
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/344379 | Compositions and methods of treating fibrotic disorders | Jan 30, 2006 | Abandoned |
Array
(
[id] => 5624858
[patent_doc_number] => 20060263363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Anti-interferon gamma antibodies and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/342020
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 25219
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11342020
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/342020 | Anti-interferon gamma antibodies and methods of use thereof | Jan 26, 2006 | Issued |
Array
(
[id] => 5624851
[patent_doc_number] => 20060263356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Antibodies against IL-13 receptor alpha1 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/325197
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16246
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263356.pdf
[firstpage_image] =>[orig_patent_app_number] => 11325197
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/325197 | Antibodies against IL-13 receptor alpha1 and uses thereof | Jan 2, 2006 | Issued |
Array
(
[id] => 4797117
[patent_doc_number] => 20080008703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Humanized Antibody Specific For Tumor Necrosis Factor-Alpha'
[patent_app_type] => utility
[patent_app_number] => 11/722094
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7897
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722094
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722094 | Humanized antibody specific for tumor necrosis factor-alpha | Dec 28, 2005 | Issued |
Array
(
[id] => 5687751
[patent_doc_number] => 20060286066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Pegylated immunoglobulin variable region polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/315848
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 53767
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11315848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/315848 | Pegylated immunoglobulin variable region polypeptides | Dec 21, 2005 | Abandoned |
Array
(
[id] => 4547626
[patent_doc_number] => 07820168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17'
[patent_app_type] => utility
[patent_app_number] => 11/305748
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9538
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11305748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/305748 | Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17 | Dec 15, 2005 | Issued |
Array
(
[id] => 5672082
[patent_doc_number] => 20060177436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods for Treating Autoimmune Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/275181
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 21823
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11275181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/275181 | Methods for Treating Autoimmune Disorders | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5872937
[patent_doc_number] => 20060165687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Vaccine adjuvant'
[patent_app_type] => utility
[patent_app_number] => 11/302505
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 6959
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11302505
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/302505 | Vaccine adjuvant | Dec 13, 2005 | Abandoned |
Array
(
[id] => 5655219
[patent_doc_number] => 20060140954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Novel human protein kinases and protein kinase-like enzymes'
[patent_app_type] => utility
[patent_app_number] => 11/299791
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 63717
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140954.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299791
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299791 | Novel human protein kinases and protein kinase-like enzymes | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5608457
[patent_doc_number] => 20060269973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens'
[patent_app_type] => utility
[patent_app_number] => 11/285970
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12632
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269973.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285970
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285970 | Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens | Nov 22, 2005 | Abandoned |
Array
(
[id] => 5747830
[patent_doc_number] => 20060110761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/269167
[patent_app_country] => US
[patent_app_date] => 2005-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35953
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110761.pdf
[firstpage_image] =>[orig_patent_app_number] => 11269167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/269167 | Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof | Nov 7, 2005 | Abandoned |
Array
(
[id] => 5618961
[patent_doc_number] => 20060188494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Method for treating established spontaneous auto-immune diseases in mammals'
[patent_app_type] => utility
[patent_app_number] => 11/266959
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2282
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188494.pdf
[firstpage_image] =>[orig_patent_app_number] => 11266959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/266959 | Method for treating established spontaneous auto-immune diseases in mammals | Nov 3, 2005 | Abandoned |
Array
(
[id] => 5608475
[patent_doc_number] => 20060269991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'T cell protein and nucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/262688
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 7991
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262688
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262688 | T cell protein and nucleotides encoding the same | Oct 30, 2005 | Abandoned |
Array
(
[id] => 246753
[patent_doc_number] => 07585504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'High affinity antibodies against HMGB1 and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/254679
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 51558
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585504.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254679 | High affinity antibodies against HMGB1 and methods of use thereof | Oct 20, 2005 | Issued |
Array
(
[id] => 5662078
[patent_doc_number] => 20060252674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Methods for pretreating a subject with extracorporeal photopheresis'
[patent_app_type] => utility
[patent_app_number] => 11/247111
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55961
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252674.pdf
[firstpage_image] =>[orig_patent_app_number] => 11247111
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/247111 | Methods for pretreating a subject with extracorporeal photopheresis | Oct 10, 2005 | Abandoned |
Array
(
[id] => 4797127
[patent_doc_number] => 20080008713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Single domain antibodies against tnfr1 and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/664542
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 75351
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11664542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664542 | Single domain antibodies against tnfr1 and methods of use therefor | Oct 6, 2005 | Abandoned |
Array
(
[id] => 581867
[patent_doc_number] => 07452981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'Humanized anti-CD4 antibody with immunosuppressive properties'
[patent_app_type] => utility
[patent_app_number] => 11/217402
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4237
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11217402
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/217402 | Humanized anti-CD4 antibody with immunosuppressive properties | Sep 1, 2005 | Issued |
Array
(
[id] => 5720787
[patent_doc_number] => 20060073562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Protein tyrosine kinase substrate LAT and its use in the indentification of (ANT)agonists of the kinase'
[patent_app_type] => utility
[patent_app_number] => 11/218020
[patent_app_country] => US
[patent_app_date] => 2005-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 32154
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218020
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218020 | Protein tyrosine kinase substrate LAT and its use in the identification of (ANT) agonists of the kinase | Aug 30, 2005 | Issued |
Array
(
[id] => 6977426
[patent_doc_number] => 20050287142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Remedies or preventives for rheumatoid arthritis'
[patent_app_type] => utility
[patent_app_number] => 11/207785
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14178
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287142.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207785
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207785 | Remedies or preventives for rheumatoid arthritis | Aug 21, 2005 | Abandoned |
Array
(
[id] => 5672091
[patent_doc_number] => 20060177445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Treatment of inflammatory skin diseases'
[patent_app_type] => utility
[patent_app_number] => 11/201558
[patent_app_country] => US
[patent_app_date] => 2005-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13174
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201558 | Treatment of inflammatory skin diseases | Aug 10, 2005 | Abandoned |